These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 24559750

  • 21. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, Konishi J.
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [Abstract] [Full Text] [Related]

  • 22. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
    Ni T, Shang XS, Wang WT, Hu XX, Zeng MS, Rao SX.
    Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
    [Abstract] [Full Text] [Related]

  • 23. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
    Yang NJ, Song B, Wu B, Xu J, Zhao LM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
    [Abstract] [Full Text] [Related]

  • 24. Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
    Piscaglia F, Iavarone M, Galassi M, Vavassori S, Renzulli M, Forzenigo LV, Granito A, Salvatore V, Sangiovanni A, Golfieri R, Colombo M, Bolondi L.
    Dig Dis; 2015 Oct; 33(6):735-44. PubMed ID: 26488875
    [Abstract] [Full Text] [Related]

  • 25. Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018.
    Shao S, Shan Q, Zheng N, Wang B, Wang J.
    Cancer Biother Radiopharm; 2019 Oct; 34(8):511-518. PubMed ID: 31314589
    [Abstract] [Full Text] [Related]

  • 26. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
    Leyendecker JR, Gakhal M, Elsayes KM, McDermott R, Narra VR, Brown JJ.
    J Comput Assist Tomogr; 2008 Oct; 32(2):178-84. PubMed ID: 18379298
    [Abstract] [Full Text] [Related]

  • 27. Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay.
    Awaya H, Ito K, Honjo K, Fujita T, Matsumoto T, Matsunaga N.
    Clin Imaging; 1998 Oct; 22(3):180-7. PubMed ID: 9559229
    [Abstract] [Full Text] [Related]

  • 28. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Choi SY, Kim YK, Min JH, Kang TW, Jeong WK, Ahn S, Won H.
    Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
    [Abstract] [Full Text] [Related]

  • 29. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images.
    Kwon HJ, Byun JH, Kim JY, Hong GS, Won HJ, Shin YM, Kim PN.
    Abdom Imaging; 2015 Jan; 40(1):64-75. PubMed ID: 24997560
    [Abstract] [Full Text] [Related]

  • 30. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma.
    Fujii T, Zen Y, Nakanuma Y.
    J Gastroenterol; 2007 Aug; 42(8):698-702. PubMed ID: 17701135
    [Abstract] [Full Text] [Related]

  • 31. [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].
    Jiang YY, Wang XY, Guo XM, Jiang XX.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec 18; 42(6):767-72. PubMed ID: 21170112
    [Abstract] [Full Text] [Related]

  • 32. Intrahepatic cholangiocarcinoma in liver hemangioma with hepatitis B infection.
    Cheng Y, Jia Q, Yang C, Cheng N.
    Dig Liver Dis; 2013 Nov 18; 45(11):e14. PubMed ID: 23791801
    [No Abstract] [Full Text] [Related]

  • 33. Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.
    Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Fujita N, Kubo Y, Aishima S, Shirabe K, Yoshiura T, Honda H.
    Diagn Interv Radiol; 2015 Nov 18; 21(2):96-104. PubMed ID: 25698097
    [Abstract] [Full Text] [Related]

  • 34. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ, Chen WX, Wu DS, Zhang WY, Zheng LR.
    Abdom Radiol (NY); 2016 May 18; 41(5):978-89. PubMed ID: 27193795
    [Abstract] [Full Text] [Related]

  • 35. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N.
    Abdom Imaging; 2015 Aug 18; 40(6):1492-9. PubMed ID: 25579172
    [Abstract] [Full Text] [Related]

  • 36. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ, Kim YK, Park HJ, Hwang J, Lee WJ.
    J Comput Assist Tomogr; 2013 Aug 18; 37(6):872-81. PubMed ID: 24270108
    [Abstract] [Full Text] [Related]

  • 37. Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence.
    Quaia E, Angileri R, Arban F, Gennari AG, Cova MA.
    Clin Imaging; 2015 Aug 18; 39(6):1032-8. PubMed ID: 26278014
    [Abstract] [Full Text] [Related]

  • 38. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.
    Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, Kako N, Matsunaga N, Hoshi H, Shiraishi J.
    AJR Am J Roentgenol; 2001 Sep 18; 177(3):637-43. PubMed ID: 11517061
    [Abstract] [Full Text] [Related]

  • 39. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK, Lee YH, Kwak HS, Kim CS, Han YM.
    Clin Imaging; 2008 Sep 18; 32(6):453-9. PubMed ID: 19006774
    [Abstract] [Full Text] [Related]

  • 40. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI.
    AJR Am J Roentgenol; 2007 Dec 18; 189(6):1428-34. PubMed ID: 18029881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.